
UNH
UnitedHealth Group IncorporatedA steady mega-cap income stock trading near fair value. Frameworks sharply disagree on it.
Mkt Cap
$358.09B
P/E
—
PEG
1.32
P/B
3.80
Dividend
2.30%
ROE
12.2%
About the business
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Price history
Drag across the chart to select a custom period — all analysis below refocuses to that window.
What this means: Price near 52-week highs despite weak framework scores — market enthusiasm is running ahead of the fundamentals most legends look at.
News & events
Next earnings
Tue, Jul 28 · consensus EPS $4.85 · last actual $7.23
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
Zacks · just now
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
Zacks · just now
This 1 Insane Nvidia Stat Explains Why Wall Street Can’t Stop Buying the Stock
24/7 Wall St. · just now
Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation
Simply Wall St. · just now
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Healthcare Dive · just now
Top Research Reports for UnitedHealth, Merck & Qualcomm
Zacks · just now